Clinical Trial Update: Pioglitazone Treatment in Polycystic Ovary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reports completion of pioglitazone evaluation for polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Odense University Hospital | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED